Delivery Order SPE2DE24D0013-SPE2D626F09FN
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, for the KIT XPERT XPRESS COV-2 FLU RSV + MOL BIO diagnostic test kit. This delivery order represents a child contract under a larger indefinite delivery vehicle and carries an ultimate completion date of January 14, 2026. The award includes no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier of molecular...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $97,920 to Cepheid Inc. for the XPert Xpress COVID-19, Influenza, RSV, and Molecular Biology test kit on January 6, 2026, with an ultimate completion date of January 14, 2026. The award carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Logistics Agency's ongoing procurement of...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,720 firm fixed-price delivery order to Cepheid Inc. on November 14, 2025, for the KIT XPERT XPRESS COVID-19, Influenza, and RSV molecular biology test kits. The contract utilizes no set-aside designation and is scheduled for ultimate completion by November 21, 2025. Cepheid, headquartered in Sunnyvale, California, is a specialized manufacturer of advanced molecular diagnostic systems and reagents, with established expertise in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800.00 by the Defense Logistics Agency Medical Supply Chain on December 17, 2025, with an ultimate completion date of December 23, 2025. The delivery order is for the KIT XPERT XPRESS COV-2 FLU RSV + MOL BIO—a rapid molecular diagnostic test kit designed to detect COVID-19, influenza, respiratory syncytial virus, and other respiratory pathogens. The...
- The Defense Logistics Agency awarded a $13.6K delivery order to Cepheid Inc. for the Xpert Xpress COVID-19/Flu/RSV molecular diagnostic kit on September 25, 2025. This firm fixed-price contract, with performance in Sunnyvale, California, represents a single delivery order with no set-aside designation. Cepheid, a leading manufacturer of molecular diagnostic solutions, supplies rapid point-of-care testing kits designed to detect multiple respiratory pathogens simultaneously, supporting the...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $5,440 to Cepheid Inc. for a COVID-19/Flu/RSV diagnostic test kit (10-test viral test) with an ultimate completion date of December 12, 2025. This delivery order, issued without a set-aside designation, represents a routine procurement of molecular diagnostic testing supplies from Cepheid's extensive portfolio of respiratory pathogen detection solutions. The place of performance is Cepheid's...
- The Defense Logistics Agency Medical Supply Chain awarded a $10,550 firm fixed-price delivery order to Cepheid Inc. on November 3, 2025, for the Kit Xpert Xpress COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) plus Molecular Biology diagnostic testing supplies. The delivery order, which will be completed by November 10, 2025, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic solutions. This contract is not subject to any small business...
- The Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $9,520 to Cepheid Inc. for the supply of COVID-19/Flu/RSV diagnostic test kits (10 tests per kit). This firm fixed-price delivery order, issued on October 6, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. This delivery order likely draws from one of Cepheid's existing...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on December 18, 2025, for COVID-19/Influenza/Respiratory Syncytial Virus (RSV) diagnostic test kits containing 10 viral tests. The contract is scheduled for completion by December 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents routine procurement of molecular diagnostic testing supplies, consistent with the Defense...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F09FNDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, for the KIT XPERT XPRESS COVID-19, FLU, RSV + MOL BIO diagnostic test kit. This delivery order, which is expected to be completed by January 22, 2026, represents a child contract under a larger indefinite delivery vehicle and carries no set-aside designation. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and reagents specializing in rapid infectious disease detection. The company's GeneXpert diagnostic platform serves as the foundation for the test kits being procured under this order, enabling multiplexed detection of respiratory pathogens including SARS-CoV-2, influenza, and respiratory syncytial virus. This delivery order aligns with Cepheid's extensive portfolio of federal contracts supporting multiple healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency. The company holds two significant indefinite delivery contracts with the VA—a $32.8 million contract with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029—which serve as primary vehicles for procuring molecular diagnostic reagents and test kits across the federal healthcare system. The DLA Medical Supply Chain procurement reflects continued federal reliance on Cepheid's diagnostic capabilities to support rapid testing for critical respiratory pathogens, particularly relevant to military medical facilities and defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/13/26 |